EXPRESSION OF MATRIX METALLOPROTEINASES IN LACRIMAL FLUID AND GENE POLYMORPHISM OF COMPLEMENT FACTOR H (CFH) IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA
The objective of our study was to evaluate production of matrix metalloproteinase–2 and -9 in lacrimal fluid, as well as СFH gene polymorphism in a group of patients with primary open-angle glaucoma. The study was performed with 120 eyes of patients with primary open-angle glaucoma (POAG) includin...
Main Authors: | V. A. Sokolov, V. G. Likhvantseva, O. N. Levanova, A. A. Nikiforov, V. A. Vygodin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2017-10-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/1354 |
Similar Items
-
Complex studies on gene polymorphisms of MMP2, MMP3, MMP9 matrix metalloproteinases and TIMP1, TIMP2 tissue inhibitors of metalloproteinases in the patients with primary open-angle glaucoma
by: A. V. Shevchenko, et al.
Published: (2023-04-01) -
The analysis of MMP2, MMP3 and MMP9 matrix metalloproteinases genes polymorphism among Russian Caucasian patients with primary open-angle glaucoma
by: A.V. Shevchenko, et al.
Published: (2023-03-01) -
Content of matrix metalloproteinases in the intraocular fluid of patients with primary open-angle glaucoma
by: V. V. Chernykh, et al.
Published: (2020-11-01) -
<i>CFH</i> (rs1061170, rs1410996), <i>KDR</i> (rs2071559, rs1870377) and KDR and CFH Serum Levels in AMD Development and Treatment Efficacy
by: Dzastina Cebatoriene, et al.
Published: (2024-04-01) -
Association between circulatory complement activation and hypertensive renal damage: a case–control study
by: Zhongli Wang, et al.
Published: (2024-12-01)